HomeCompareVBIZF vs JEPI

VBIZF vs JEPI: Dividend Comparison 2026

VBIZF yields 582.41% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBIZF wins by $397.8K in total portfolio value
10 years
VBIZF
VBIZF
● Live price
582.41%
Share price
$0.34
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$426.8K
Annual income
$1,230.52
Full VBIZF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — VBIZF vs JEPI

📍 VBIZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBIZFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBIZF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBIZF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBIZF
Annual income on $10K today (after 15% tax)
$49,504.95/yr
After 10yr DRIP, annual income (after tax)
$1,045.94/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, JEPI beats the other by $253.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBIZF + JEPI for your $10,000?

VBIZF: 50%JEPI: 50%
100% JEPI50/50100% VBIZF
Portfolio after 10yr
$227.9K
Annual income
$1,379.57/yr
Blended yield
0.61%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBIZF buys
0
JEPI buys
0
No recent congressional trades found for VBIZF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBIZFJEPI
Forward yield582.41%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$426.8K$29.0K
Annual income after 10y$1,230.52$1,528.62
Total dividends collected$260.9K$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VBIZF vs JEPI ($10,000, DRIP)

YearVBIZF PortfolioVBIZF Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$39,821$29,120.56$11,260$840.19+$28.6KVBIZF
2$96,795$54,186.77$12,641$907.94+$84.2KVBIZF
3$165,120$61,549.43$14,150$978.20+$151.0KVBIZF
4$225,742$49,063.40$15,795$1,050.85+$209.9KVBIZF
5$272,888$31,344.13$17,584$1,125.74+$255.3KVBIZF
6$309,696$17,705.77$19,526$1,202.74+$290.2KVBIZF
7$340,764$9,389.71$21,628$1,281.69+$319.1KVBIZF
8$369,445$4,827.89$23,898$1,362.43+$345.5KVBIZF
9$397,752$2,445.91$26,347$1,444.79+$371.4KVBIZF
10$426,826$1,230.52$28,982$1,528.62+$397.8KVBIZF

VBIZF vs JEPI: Complete Analysis 2026

VBIZFStock

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.

Full VBIZF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this VBIZF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBIZF vs SCHDVBIZF vs OVBIZF vs KOVBIZF vs MAINVBIZF vs JEPQVBIZF vs XYLDVBIZF vs DIVOVBIZF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.